Not Tagged
Not Tagged
['bcsm']
#asco22 #bcsm 8/80 pts (10%) had mrd at any time. 6 pts (7.2%) developed distant #metastatic recurrence, all of whom were mrd before overt clinical recurrence, w/ median ctdna lead time 1 2 months. mrd was not identified in 1 patient (1.2%) w/ local recurrence. #radonc 
radiation oncologist @MSKCancerCenter | #bcsm + #metastatic dz | #HSR #impsci | visiting scholar @PC3Innovation | #PeloASTRO ?? ?